Combining two large clinical cohorts (AIBL and ADNI) to identify multiple lipid metabolic pathways in prevalent and incident Alzheimer’s disease
View ORCID ProfileKevin Huynh, View ORCID ProfileWei Ling Florence Lim, View ORCID ProfileCorey Giles, Kaushala S Jayawardana, Agus Salim, Natalie A Mellett, Alex Smith, View ORCID ProfileGavriel Olshansky, Brian G Drew, View ORCID ProfilePratishtha Chatterjee, Ian Martins, View ORCID ProfileSimon M Laws, View ORCID ProfileAshley I Bush, View ORCID ProfileChristopher C Rowe, Victor L Villemagne, David Ames, View ORCID ProfileColin L Masters, View ORCID ProfileMatthias Arnold, View ORCID ProfileKwangsik Nho, View ORCID ProfileAndrew J Saykin, View ORCID ProfileRebecca Baillie, Xianlin Han, Rima Kaddurah-Daouk, View ORCID ProfileRalph N Martins, View ORCID ProfilePeter J Meikle
doi: https://doi.org/10.1101/2020.05.26.20114215
Kevin Huynh
aBaker Heart and Diabetes Institute, Melbourne, Australia
bMonash University, Melbourne, Victoria 3800, Australia
Wei Ling Florence Lim
cSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia
dCooperative research Centre (CRC) for Mental Health, Australia
Corey Giles
aBaker Heart and Diabetes Institute, Melbourne, Australia
Kaushala S Jayawardana
aBaker Heart and Diabetes Institute, Melbourne, Australia
Agus Salim
aBaker Heart and Diabetes Institute, Melbourne, Australia
eDepartment of Mathematics and Statistics, La Trobe University
Natalie A Mellett
aBaker Heart and Diabetes Institute, Melbourne, Australia
Alex Smith
aBaker Heart and Diabetes Institute, Melbourne, Australia
Gavriel Olshansky
aBaker Heart and Diabetes Institute, Melbourne, Australia
Brian G Drew
aBaker Heart and Diabetes Institute, Melbourne, Australia
bMonash University, Melbourne, Victoria 3800, Australia
Pratishtha Chatterjee
cSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia
fDepartment of Biomedical Sciences, Macquarie University, North Ryde, New South Wales, Australia
gKaRa Institute of Neurological Disease, Sydney, Macquarie Park, New South Wales, Australia
Ian Martins
dCooperative research Centre (CRC) for Mental Health, Australia
Simon M Laws
cSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia
hCollaborative Genomics Group, School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia
iSchool of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin Health Innovation Research Institute, Curtin University, Western Australia, Australia
Ashley I Bush
jThe Florey Department of Neuroscience and Mental Health, The University of Melbourne, Victoria, 3010, Australia
Christopher C Rowe
jThe Florey Department of Neuroscience and Mental Health, The University of Melbourne, Victoria, 3010, Australia
kDepartment of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia
Victor L Villemagne
kDepartment of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia
lDepartment of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
David Ames
mNational Ageing Research Institute, Parkville, Victoria, 3050, Australia
Colin L Masters
jThe Florey Department of Neuroscience and Mental Health, The University of Melbourne, Victoria, 3010, Australia
Matthias Arnold
nDepartment of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
oInstitute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
Kwangsik Nho
pDepartment of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis IN, USA
qCeter for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN, USA
rIndiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, IN, USA
Andrew J Saykin
pDepartment of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis IN, USA
rIndiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, IN, USA
sDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA
Rebecca Baillie
tRosa & Co LLC, San Carlos, CA, USA
Xianlin Han
uBarshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
Rima Kaddurah-Daouk
nDepartment of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
vDuke Institute of Brain Sciences, Duke University, Durham, NC, USA
wDepartment of Medicine, Duke University, Durham, NC, USA
Ralph N Martins
cSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia
dCooperative research Centre (CRC) for Mental Health, Australia
fDepartment of Biomedical Sciences, Macquarie University, North Ryde, New South Wales, Australia
gKaRa Institute of Neurological Disease, Sydney, Macquarie Park, New South Wales, Australia
xSchool of Psychiatry and Clinical Neurosciences, The University of Western Australia, Perth, Australia
yAustralian Alzheimer’s Research Foundation, Nedlands, Western Australia, Australia
Peter J Meikle
aBaker Heart and Diabetes Institute, Melbourne, Australia
bMonash University, Melbourne, Victoria 3800, Australia
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted May 28, 2020.
Combining two large clinical cohorts (AIBL and ADNI) to identify multiple lipid metabolic pathways in prevalent and incident Alzheimer’s disease
Kevin Huynh, Wei Ling Florence Lim, Corey Giles, Kaushala S Jayawardana, Agus Salim, Natalie A Mellett, Alex Smith, Gavriel Olshansky, Brian G Drew, Pratishtha Chatterjee, Ian Martins, Simon M Laws, Ashley I Bush, Christopher C Rowe, Victor L Villemagne, David Ames, Colin L Masters, Matthias Arnold, Kwangsik Nho, Andrew J Saykin, Rebecca Baillie, Xianlin Han, Rima Kaddurah-Daouk, Ralph N Martins, Peter J Meikle
medRxiv 2020.05.26.20114215; doi: https://doi.org/10.1101/2020.05.26.20114215
Combining two large clinical cohorts (AIBL and ADNI) to identify multiple lipid metabolic pathways in prevalent and incident Alzheimer’s disease
Kevin Huynh, Wei Ling Florence Lim, Corey Giles, Kaushala S Jayawardana, Agus Salim, Natalie A Mellett, Alex Smith, Gavriel Olshansky, Brian G Drew, Pratishtha Chatterjee, Ian Martins, Simon M Laws, Ashley I Bush, Christopher C Rowe, Victor L Villemagne, David Ames, Colin L Masters, Matthias Arnold, Kwangsik Nho, Andrew J Saykin, Rebecca Baillie, Xianlin Han, Rima Kaddurah-Daouk, Ralph N Martins, Peter J Meikle
medRxiv 2020.05.26.20114215; doi: https://doi.org/10.1101/2020.05.26.20114215
Subject Area
Subject Areas
- Addiction Medicine (344)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2634)
- Dermatology (222)
- Emergency Medicine (398)
- Epidemiology (12197)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4074)
- Geriatric Medicine (387)
- Health Economics (679)
- Health Informatics (2634)
- Health Policy (1000)
- Hematology (362)
- HIV/AIDS (848)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (432)
- Neurology (3851)
- Nursing (209)
- Nutrition (572)
- Oncology (2013)
- Ophthalmology (584)
- Orthopedics (239)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1111)
- Primary Care Research (449)
- Public and Global Health (6506)
- Radiology and Imaging (1393)
- Respiratory Medicine (870)
- Rheumatology (401)
- Sports Medicine (342)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)